Faes Farma Reports First Quarter 2025 Earnings

Simply Wall St · 05/08 04:48

Faes Farma (BME:FAE) First Quarter 2025 Results

Key Financial Results

  • Revenue: €153.0m (up 10% from 1Q 2024).
  • Net income: €28.4m (down 6.9% from 1Q 2024).
  • Profit margin: 19% (down from 22% in 1Q 2024).
  • EPS: €0.091.
earnings-and-revenue-growth
BME:FAE Earnings and Revenue Growth May 8th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Faes Farma Earnings Insights

Looking ahead, revenue is forecast to grow 6.2% p.a. on average during the next 3 years, compared to a 8.3% growth forecast for the Pharmaceuticals industry in Spain.

Performance of the Spanish Pharmaceuticals industry.

The company's share price is broadly unchanged from a week ago.

Risk Analysis

It's still necessary to consider the ever-present spectre of investment risk. We've identified 2 warning signs with Faes Farma, and understanding these should be part of your investment process.